BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma

Clinical trial NCT07196124 · WITHDRAWN

Trial details

NCT number: NCT07196124
Sponsor: Guangzhou Bio-gene Technology Co., Ltd
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Refractory

Start date: 2025-10-10
Primary completion: 2028-10-09
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.